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Carbon monoxide (CO) is an odorless, colorless, poisonous gas that can cause sudden illness and death 
if present in sufficient concentration in the ambient air. During a significant power outage, persons using 
alternative fuel or power sources such as generators or gasoline powered engine tools such as pressure 
washers might be exposed to toxic CO levels if the fuel or power sources are placed inside or too close to 
the exterior of the building causing CO to build up in the structure. The purpose of this HAN advisory is to 
remind clinicians evaluating persons affected by the storm to maintain a high index of suspicion for CO 
poisoning. Clinicians are advised to consider CO exposure and take steps to discontinue exposure to CO. 
Clinicians are also advised to ask a patient with CO poisoning about other people who may be exposed to 
the same CO exposure, such as persons living with or visiting them so they may be treated for possible 
CO poisoning.  
 
Background 
Hurricane Harvey made landfall between Port Aransas and Port O’Connor, Texas on August 25, 2017, 
causing 300,000 persons to lose power. When power outages occur during emergencies such as 
hurricanes or winter storms, the use of alternative sources of fuel or electricity for heating, cooling, or 
cooking can cause CO to build up in a home, garage, or camper and poison the people and animals 
inside. Although CO poisoning can be fatal to anyone, children, pregnant women, and older adults as well 
as persons with chronic illness are particularly vulnerable to CO poisoning. The symptoms and signs of 
CO poisoning are variable and nonspecific. The most common symptoms of CO poisoning are headache, 
dizziness, weakness, nausea, vomiting, chest pain, and altered mental status. Symptoms of severe CO 
poisoning include malaise, shortness of breath, headache, nausea, chest pain, irritability, ataxia, altered 
mental status, other neurologic symptoms, loss of consciousness, coma, and death. Signs and clinical 
manifestations of severe CO poisoning include tachycardia, tachypnea, hypotension, various neurologic 
findings including impaired memory, cognitive and sensory disturbances, metabolic acidosis, arrhythmias, 
myocardial ischemia or infarction, and noncardiogenic pulmonary edema, although any organ system 
might be involved.  
 
An elevated carboxyhemoglobin (COHgb) level of 2% or higher for non-smokers and 9% or higher 
COHgb level for smokers strongly supports a diagnosis of CO poisoning. The COHgb level must be 
interpreted in light of the patient’s exposure history and length of time away from CO exposure, as levels 
gradually fall once the patient is removed from the exposure. 
 
With a focused history, exposure to a CO source may become apparent; items in the history that might 
trigger a higher index of suspicion for CO poisoning in this setting include lack of a fever, recurrent 
symptoms, and multiple family members affected by similar symptoms. Appropriate and prompt 
diagnostic testing and treatment are crucial to reduce morbidity and prevent mortality from CO poisoning. 
Recommendations 
CDC recommends that clinicians: 
1) Consider CO poisoning in persons affected by Hurricane Harvey, particularly persons who are 
currently without power. All people affected by the storm should be advised about safe practices 
related to generators, grills, camp stoves, or other gasoline, propane, natural gas, or charcoal-burning 
devices, including that these devices should never be used inside a home, basement, garage, or 
camper — or even outside near an open window or window air conditioner. Please see 
https://www.cdc.gov/co/pdfs/generators.pdf.  
2) Ask patients presenting for treatment who are affected by Harvey about symptoms consistent with 
CO poisoning. Clinicians should also ask about exposure to any fuel or power sources that place a 
person at increased risk for CO poisoning, including gas-powered generators, charcoal grills, propane 
stoves, charcoal briquettes, and other indoor heating and cooking devices.  Evaluation should also 
include examination for other conditions, including smoke inhalation, trauma, medical illness, or 
intoxication. 
3) Administer 100% oxygen to persons in whom a diagnosis of CO poisoning is known or suspected 
until the patient is symptom-free or until a diagnosis of CO poisoning has been ruled out. Duration of 
oxygen treatment in persons with CO poisoning is usually about 4–5 hours.  
4) Perform COHgb testing when the diagnosis of CO poisoning is being considered. The most common 
technology available in hospital laboratories for analyzing the blood is the multiple wavelength 
spectrophotometer, also known as a CO-oximeter. Venous or arterial blood may be used for testing. 
A fingertip pulse CO-oximeter can be used to measure heart rate, oxygen saturation, and COHgb 
levels in the field, but suspicion of CO poisoning should be confirmed with a COHgb level by CO-
oximeter. A conventional two-wavelength pulse oximeter is not accurate when COHgb is present. For 
more information, see https://www.cdc.gov/disasters/co_guidance.html. 
5) An elevated carboxyhemoglobin (COHgb) level of 2% or higher for non-smokers and 9% or higher 
COHgb level for smokers strongly supports a diagnosis of CO poisoning. The COHgb level must be 
interpreted in light of the patient’s exposure history and length of time away from CO exposure, as 
levels gradually fall once the patient is removed from the exposure. In addition, carbon monoxide can 
be produced endogenously as a byproduct of heme metabolism. Patients with sickle cell disease can 
have an elevated COHgb level as a result of hemolytic anemia or hemolysis. For additional 
information about interpretation of COHgb levels, visit 
https://www.cdc.gov/disasters/co_guidance.html or call Poison Control at (800) 222-1222. 
6) Hyperbaric oxygen therapy (HBO) should be considered when the patient has a COHgb level of more 
than 25–30%, there is evidence of cardiac involvement, severe acidosis, transient or prolonged 
unconsciousness, neurological impairment, abnormal neuropsychiatric testing, or the patient is ≥36 
years in age. HBO is also administered at lower COHgb (<25%) levels if suggested by clinical 
condition and/history of exposure. For pregnant women, hyperbaric oxygen is the treatment of choice, 
even if they are less severely poisoned. Hyperbaric oxygen is safe to administer and international 
consensus favors it as part of a more aggressive role in treating pregnant women. For additional 
management considerations, consult a toxicologist, Poison Control at (800) 222-1222, or a hyperbaric 
oxygen facility. 
7) Be aware that CO exposure may be still occurring in other people residing with or visiting CO 
poisoned patients. Clinicians treating people for CO poisoning should ask whether other persons 
living with or visiting the poisoned individual are currently being exposed to CO and notify emergency 
medical services (EMS), the fire department, or law enforcement as applicable in their area. The CO 
exposure should be eliminated, and other persons who might be poisoned should be evaluated and 
tested as described in this advisory. 
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